Identifying the E2F3-MEX3A-KLF4 Signaling Axis That Sustains Cancer Cells in Undifferentiated and Proliferative State
Xu Yang,Guilin Li,Yuhua Tian,Xin Wang,Jiuzhi Xu,Ruiqi Liu,Min Deng,Chunlei Shao,Yuwei Pan,Xi Wu,Mengzhen Li,Chaowei Zhang,Rui Liu,Jun Qin,Chen Zhang,Zhanju Liu,Xin Wu,Maksim Plikus,Christopher J. Lengner,Zongheng Zheng,Cong Lv,Zhengquan Yu
DOI: https://doi.org/10.7150/thno.76619
IF: 11.6
2022-01-01
Theranostics
Abstract:Rationale: Dysregulation of signaling that governs self-renewal and differentiation of intestinal stem cells (ISCs) is a major cause of colorectal cancer (CRC) initiation and progression. Methods: qRT-PCR, western blotting, in situ hybridization, immunohistochemistry and immunofluorescence assays were used to detect the expression levels of MEX3A, KLF4 and E2F3 in CRC tissues. The biological functions of MEX3A were studied using Mex3a knockout (KO) and intestinal epithelium specific conditional knockout (cKO) mice, AOM-DSS mouse colorectal tumor model, Apc floxed mouse tumor model and intestinal and tumor organoids. Transcriptomic RNA sequencing (RNA-seq), RNA crosslinking immunoprecipitation (CLIP) and luciferase reporter assays were performed to explore the molecular mechanisms of MEX3A. Results: RNA-binding protein MEX3A, a specific ISC marker gene, becomes ectopically upregulated upon CRC and its levels negatively correlate with patient survival prognosis. MEX3A functions as an oncoprotein that retains cancer cells in undifferentiated and proliferative status and it enhances their radioresistance to DNA damage. Mechanistically, a rate limiting factor of cellular proliferation E2F3 induces MEX3A, which in turn activates WNT pathway by directly suppressing expression of its pro-differentiation transcription factor KLF4. Knockdown of MEX3A with siRNA or addition of KLF4 agonist significantly suppressed tumor growth both by increasing differentiation status of cancer cells and by suppressing their proliferation. Conclusions: It identifies E2F3-MEX3A-KLF4 axis as an essential coordinator of cancer stem cell self-renewal and differentiation, representing a potent new druggable target for cancer differentiation therapy.